Meili Technology: Meili, a wholly-owned subsidiary, plans to purchase assets related to MSSC AHLE GmbH for 8.1 million euros. Meili, a wholly-owned subsidiary of Meili Technology, signed an Asset Purchase Agreement with MSSC AHLE GmbH(AHLE Company) on December 10, 2024 to purchase assets related to AHLE Company's business at a transaction consideration of 8.1 million euros, including factory buildings, production equipment, inventory, intangible assets, contractual rights, etc. AHLE Company was established in 1904, and its main business is spring research and development, manufacturing, sales and trade, etc. Its main products include automobile suspension springs, brake chamber springs and recovery springs, and its customers include Volkswagen, ZF and other OEMs and first-class suppliers. Due to operational difficulties, the bankruptcy court in Cologne, Germany, initiated bankruptcy proceedings on the property of AHLE Company on October 1, 2024. Germany Meili purchased these assets by auction, and the transaction price was based on the Financial Due Diligence Report and the Legal Due Diligence Report issued by a third-party intermediary agency, taking into account the market position, channels, customers and future market opportunities of the subject matter of the transaction.Adobe's US stocks fell about 9% before the market, and the company's annual performance guidance was worse than expected.Russia is willing to engage with the United States on the Ukrainian issue. Russian Foreign Ministry spokesman Zacharova said at a regular press conference on the 11th that Russia is willing to engage with the United States on the Ukrainian issue, but has not received any "serious suggestions" from the team of President-elect Trump.
Japan's Shimane nuclear power plant operating company said that there was no abnormality in the reactor water level gauge of Unit 2, which was previously misjudged. On December 12, local time, China Electric Power Company of Japan conducted an investigation on the report that the reactor water level gauge of Unit 2 of Shimane nuclear power plant was once abnormal, and the results showed that there was no abnormality. The company said that the value displayed by the instrument was normal, but the operator misunderstood the data and misjudged it as abnormal. (CCTV News)Dashengda and Tuopai Shede Group set up investment partnerships. According to the enterprise search APP, Sichuan Fujiang Yingke Investment Partnership (Limited Partnership) was recently established with a capital contribution of 200 million yuan. Its business scope includes: asset management services invested by its own funds; Enterprise management consulting; Information technology consulting service. Enterprise equity penetration shows that the enterprise is jointly held by Dashengda and Sichuan Tuopai Shede Group Co., Ltd..IEA Monthly Report: The daily output of the refinery will reach the annual peak of 84.3 million barrels in December. It is estimated that in 2024, the daily output of the refinery will increase by 520,000 barrels to an average of 82.7 million barrels per day. It is estimated that in 2025, the daily output of refineries will increase by 620,000 barrels to an average of 83.3 million barrels per day.
IEA Monthly Report: The daily output of the refinery will reach the annual peak of 84.3 million barrels in December. It is estimated that in 2024, the daily output of the refinery will increase by 520,000 barrels to an average of 82.7 million barrels per day. It is estimated that in 2025, the daily output of refineries will increase by 620,000 barrels to an average of 83.3 million barrels per day.Mengke Pharmaceutical Co., Ltd.: The new packaging of Contizontamide tablets will be on the market soon. Mengke Pharmaceutical Co., Ltd. announced that the company has launched Contizontamide tablets with new packaging specifications, and a box of 12 tablets will be on the market soon. Contizontamide tablet is a new class 1 oxazolidinone antibacterial drug with global intellectual property rights. It was approved by National Medical Products Administration, China on June 1st, 2021 for the treatment of complex skin and soft tissue infections.In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for generic drug substitution. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14